| Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy D Gyori, EL Lim, FM Grant, D Spensberger, R Roychoudhuri, ... JCI insight 3 (11), 2018 | 111 | 2018 |
| Class IA phosphoinositide 3-kinase β and δ regulate neutrophil oxidase activation in response to Aspergillus fumigatus hyphae KB Boyle, D Gyori, A Sindrilaru, K Scharffetter-Kochanek, PR Taylor, ... The Journal of Immunology 186 (5), 2978-2989, 2011 | 85 | 2011 |
| Osteoclast signal transduction during bone metastasis formation DS Győri, A Mócsai Frontiers in cell and developmental biology 8, 507, 2020 | 69 | 2020 |
| CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function SK Whiteside, FM Grant, DS Gyori, AG Conti, CJ Imianowski, P Kuo, ... Immunology 163 (4), 512-520, 2021 | 52 | 2021 |
| Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitors EL Lim, FM Cugliandolo, DR Rosner, D Gyori, R Roychoudhuri, ... JCI insight 3 (11), 2018 | 45 | 2018 |
| Extracellular vesicles regulate the human osteoclastogenesis: divergent roles in discrete inflammatory arthropathies N Marton, OT Kovács, E Baricza, Á Kittel, D Győri, A Mócsai, FMP Meier, ... Cellular and Molecular Life Sciences 74, 3599-3611, 2017 | 44 | 2017 |
| Nicotinic acetylcholine receptors modulate osteoclastogenesis P Mandl, S Hayer, T Karonitsch, P Scholze, D Győri, D Sykoutri, S Blüml, ... Arthritis Research & Therapy 18, 1-12, 2016 | 38 | 2016 |
| Phospholipase Cγ2 is required for basal but not oestrogen deficiency–induced bone resorption Z Kertész, D Győri, S Körmendi, T Fekete, K Kis‐Tóth, Z Jakus, G Schett, ... European journal of clinical investigation 42 (1), 49-60, 2012 | 38 | 2012 |
| Class (I) phosphoinositide 3-kinases in the tumor microenvironment D Gyori, T Chessa, PT Hawkins, LR Stephens Cancers 9 (3), 24, 2017 | 36 | 2017 |
| The phosphoinositide 3‐kinase isoform PI3Kβ regulates osteoclast‐mediated bone resorption in humans and mice D Győri, D Csete, S Benkő, S Kulkarni, P Mandl, C Dobó‐Nagy, ... Arthritis & Rheumatology 66 (8), 2210-2221, 2014 | 32 | 2014 |
| Hematopoietic or osteoclast-specific deletion of Syk leads to increased bone mass in experimental mice D Csete, E Simon, A Alatshan, P Aradi, C Dobó-Nagy, Z Jakus, S Benkő, ... Frontiers in Immunology 10, 443477, 2019 | 28 | 2019 |
| Fluorescence-based real-time analysis of osteoclast development Á Pánczél, SP Nagy, J Farkas, Z Jakus, DS Győri, A Mócsai Frontiers in Cell and Developmental Biology 9, 657935, 2021 | 5 | 2021 |
| Osteoclasts in inflammation D Győri, A Mócsai Berlin: Springer, 2015 | 4 | 2015 |
| Research update for articles published in EJCI in 2012 RPF Dullaart, NM Al‐Daghri, M Ashina, A Bouzas‐Mosquera, ND Brunetti, ... European Journal of Clinical Investigation 44 (10), 1010-1023, 2014 | 1 | 2014 |
| De novo steroidogenesis in tumor cells drives bone metastasis and osteoclastogenesis LF Sandor, JB Huh, P Benko, T Hiraga, S Poliska, C Dobo-Nagy, ... Cell Reports 43 (3), 2024 | | 2024 |
| Local Effects of Steroid Hormones within the Bone Microenvironment LF Sandor, R Ragacs, DS Gyori International Journal of Molecular Sciences 24 (24), 17482, 2023 | | 2023 |
